Elenco degli articoli con argomento «brodalumab»
Dermatologia17 lug 2023
Interleukin-17 pathway inhibition with brodalumab in early systemic sclerosis
Analysis of a single-arm, open-label, phase 1 trial
15 ott 2019
Psoriasi: farmaci biologici sempre più efficaci e sicuri
Gli anticorpi migliorano significativamente i sintomi della malattia. No al “fai da te”. Sul web troppi video privi di contenuto scientifico
24 ott 2017
Brodalumab Achieves Superior Lesion Clearance Compared With Secukinumab and Ustekinumab in Moderate-to-Severe Psoriasis
More patients with moderate-to-severe psoriasis achieved "clear" or "almost clear" status with brodalumab than with secukinumab using Psoriasis Area and Severity (PASI) scores
10 ott 2017
Brodalumab Shows Sustained Efficacy in Treating Moderate-to-Severe Psoriasis
Brodalumab achieved high levels of lesion clearance in the majority of patients with moderate-to-severe psoriasis, with results sustained through 120 weeks
10 ott 2017
Switching to Brodalumab From Ustekinumab Improves Clearance in Moderate-to-Severe Psoriasis
Patients with moderate-to-severe psoriasis that did not adequately respond to ustekinumab achieve high levels of lesion clearance after switching to brodalumab rescue therapy
27 feb 2017
FDA Approves Brodalumab to Treat Psoriasis
The US Food and Drug Administration (FDA) has approved brodalumab (Siliq) to treat adults with moderate-to-severe plaque psoriasis. Brodalumab is administered as an injection.
02 ott 2015
Investigational Drug Brodalumab Effective for Patients With Psoriasis
An experimental, biologic treatment, brodalumab, appears to be more effective than ustekinumab in reducing psoriasis symptoms